Neoadjuvant Chemotherapy: Transforming Treatmen...

By Rene Pretorius

October 25, 2024

Neoadjuvant chemotherapy (NACT) followed by interval cytoreductive surgery (ICS) has become the leading initial treatment for advanced epithelial ovarian cancer (EOC). This approach offers ad...
CTO-PCI Technology for Heart Health in Egypt
NICE Rejects Donanemab for NHS Use Due to Cost Concerns
Impact of Health Insurance on Advanced Prostate Cancer Treatment Costs
Congo Launches Mpox Vaccination Campaign to Address Outbreak
Saudi Healthcare Reform: Vision 2030 and Beyond
Transforming Value-Based Oncology Care: A Multifaceted Approach
Bupa Launches Whole Genome Sequencing Pilot in UK
HARMONi-2 Trial Results Transforming NSCLC
KEYTRUDA Head Neck Cancer Phase 3 Trial
UNAIDS Urges Greater Access for Gilead’s Lenacapavir
Global AIDS Update 2024: Progress and Challenges
Early Prevention of Obesity: Tackling from Conception